8-K: Greenpro Capital Acquires Stake in Greenophene Tech

Greenpro Capital Corp. announced the acquisition of a 0.99% stake in Greenophene Technologies Limited for $1.2 million, paid in restricted common stock.

Summary

• Greenpro Capital Corp. (GRNQ) entered into an Acquisition Agreement on November 18, 2025, with Lim Chee Yin (the Seller).
• The Company will acquire 0.99% of the Seller's shareholdings in Greenophene Technologies Limited (GTL), a British Virgin Islands company, equivalent to 10 shares of GTL.
• The aggregate closing consideration for the acquisition is US$1,200,000.
• This consideration will be satisfied by issuing 800,000 shares of Greenpro Common Stock, valued at US$1.50 per share.
• The shares issued as consideration will be restricted under Rule 144 of the Securities Act of 1933.
• All 800,000 shares will be held in escrow and remain under the Company's control until the closing of the acquisition.
• The issuance of these shares is exempt from registration requirements under Regulation D, specifically Rule 506, of the Securities Act.

Sentiment

Score: 6

Explanation: The acquisition represents a strategic move into the technology sector, which can be positive for long-term growth, despite the immediate dilution from share issuance and the small stake acquired.

Positives

• Strategic investment in Greenophene Technologies Limited, potentially expanding Greenpro Capital's portfolio into the technology sector.
• The acquisition is structured with shares held in escrow, providing a level of control until closing.

Negatives

• The issuance of 800,000 new common shares will result in dilution for existing Greenpro Capital Corp. shareholders.
• The acquired stake is a small minority interest (0.99%) in Greenophene Technologies Limited, limiting direct control or significant influence.

Risks

• The 800,000 shares issued as consideration are restricted under Rule 144 of the Securities Act, limiting their immediate liquidity for the Seller.
• All 800,000 shares will be held in escrow and remain under the control of Greenpro Capital Corp. until the closing of the acquisition, indicating conditions precedent to full transfer.

Future Outlook

The filing primarily details a completed agreement for an acquisition. It does not provide broader forward-looking statements or guidance beyond the consummation of this specific transaction.

Management Comments

• The Acquisition Agreement contains customary representations, warranties, and covenants made by both parties, including authorization, enforceability, compliance with securities laws, absence of undisclosed liabilities, and the Seller's obligation to assist with Schedule 13D and other required SEC beneficial ownership filings.

Industry Context

This acquisition represents Greenpro Capital Corp.'s strategic investment in a technology company, Greenophene Technologies Limited, indicating a potential diversification or expansion into the technology sector. Such investments are common for capital firms seeking growth opportunities in emerging or specialized technology areas.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Experience dilution due to the issuance of 800,000 new common shares, but potentially benefit from the strategic investment in Greenophene Technologies Limited.
• Seller (Lim Chee Yin): Receives 800,000 restricted shares of Greenpro Capital Corp. common stock as consideration for the sale of GTL shares.

Next Steps

• Consummation of the transaction contemplated in the Acquisition Agreement (the Closing).
• The Seller's obligation to assist with Schedule 13D and other required SEC beneficial ownership filings.

Key Dates

Keywords

Acquisition, Greenpro Capital, Greenophene Technologies, GRNQ, Equity Issuance, Restricted Stock, Regulation D, SEC Filing, Investment